What to Know About the New COVID-19 Variant NB.1.8.1

Public health experts have warned for several months that the Covid-19 virus did not disappear-and away from the retreat, SARS-COV-2 mutated again to a new variable. It is called NB.1.8.1, and it causes an increase in infections in China. A few cases also appeared in the United States in the United States when people arrived at positive airports, according to a statement issued by the United States Centers to control diseases and prevent them (CDC). The World Health Organization also has specific It is “changing under observation.”

Here is what to know about the new alternative.

Where did NB.1.8.1 come from?

Data from JisideA global database of the genetic sequences of the main pathogens viruses appears, the first known cases of NB.1.8.1 at the end of April, appearing in travelers from China, France, Japan, the Netherlands, Spain, South Korea, Taiwan and Thailand.

NB.1.8.1 is now the dominant Covid-19 strain in China, as it contributes to nails to the emergency room visits and hospital entry.

Where is the new Covid-19 variable in the United States?

the CDC runs a program In many airports in the United States, where health officials are randomly testing travelers who agree to the anointing. The new alternative was captured through this program, which begins in late March. Cases have now been reported in a handful of states, including California, Hawaii, New York, Ouhayu, Roses Island, Verginia and Washington. Until now, only a few cases have been discovered in the United States so that they are not yet registered at the Disease Control Center Covid-19 data tracking Variables site.

Will the last Covid-19 vaccine protect me?

NB.1.8.1 is still part of the omicron family, which means that current vaccines and immunity of modern infections should provide some protection against serious diseases.

Read more: How a child changes under Trump

The new alternative is also on the radars of pharmaceutical companies. Checks Committee of Experts of American Food and Food Experts (FDA) He met May 22 To discuss whether or not the vaccine will be updated for the autumn and winter respiratory season, and I have heard about Pfizer and Moderna vaccine data on experimental vaccines targeting LP.8.1, which is currently represented More than 70 % From Covid-19 cases in the United States (LP.8.1 is associated with NB.1.8.1 and to the strain currently targeting vaccines, JN.1.) These experimental vaccines seem to provide slightly stronger protection against both variables.

In the end, the committee voted on recommending the continuation of the JN.1 vaccine – but it did not specify whether the updated shot should target LP.8.1.

What are the symptoms of NB.1.8.1?

Symptoms are similar to those associated with other Covid-19 strains that include sore throat, fever, cough and fatigue. Until now, based on data from other countries where cases have been reported, the alternative does not seem to cause a more severe – but genetic disease, and it is equipped with changes that allow them to cells more efficiently. This means that it can spread easily among people.

How do I protect myself from the new alternative?

Vaccination can increase the chances of avoiding severe disease, because the current vaccine still protects against NB.1.8.1 viruses. This is especially true for people at risk of severe diseases, including the elderly and those who suffer from weakening of the immune system.

Read more: What the report “Make America is healthy again” on the health of children

Getting vaccination, however, may become more difficult for other groups. In a series of extraordinary moves, US Health Minister Robert F. announced. Kennedy Junior said that the Center for Disease Control will no longer be recommended for an annual photography Healthy children and pregnant women; The Food and Drug Administration (FDA) recently said it will not recommend it to healthy adults until vaccine makers Additional studies To prove its safety and effectiveness in this category of population.